DOI: 10.1128/AAC.01624-18
Article Information
PubMed
Published By
History
- Received August 2, 2018
- Returned for modification August 21, 2018
- Accepted September 5, 2018
- Published online November 26, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (September 17, 2018).
- You are viewing the most recent version of this article.
Author Information
- aUnit of Mycology, Statens Serum Institut, Copenhagen, Denmark
- bInstitute of Microbiology, University of Lausanne, University Hospital Center, Lausanne, Switzerland
- cDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
- dDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
- Address correspondence to M. C. Arendrup, maca{at}ssi.dk.
↵* Present address: K. M. T. Astvad, Department of Clinical Microbiology, Hvidovre University Hospital, Hvidovre, Denmark.
Citation Astvad KMT, Sanglard D, Delarze E, Hare RK, Arendrup MC. 2018. Implications of the EUCAST trailing phenomenon in Candida tropicalis for the in vivo susceptibility in invertebrate and murine models. Antimicrob Agents Chemother 62:e01624-18. https://doi.org/10.1128/AAC.01624-18.
